Monoamine Oxidase a Binding in Major Depressive Disorder and in Cigarette Withdrawal

被引：0
|
作者：
Meyer, Jeffrey Hugh [1 ]
机构：
[1] Coll Site, Ctr Addict & Mental Hlth, Toronto, ON, Canada
来源：
BIOLOGICAL PSYCHIATRY | 2010年 / 67卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
661
引用
收藏
页码：186S / 187S
页数：2
相关论文
共 50 条
  • [31] Associations Among Monoamine Neurotransmitter Pathways, Personality Traits, and Major Depressive Disorder
    Shao, Xiaojun
    Zhu, Gang
    FRONTIERS IN PSYCHIATRY, 2020, 11
  • [32] Monoamine oxidase: A gene poly polymorphism and antidepressant orphism, tryptophan hydroxylase gene response to fluvoxamine in Japanese patients with major depressive disorder
    Yoshida, K
    Naito, S
    Takahashi, H
    Sato, K
    Ito, K
    Kamata, M
    Higuchi, H
    Shimizu, T
    Itoh, K
    Inoue, K
    Tezuka, T
    Suzuki, T
    Ohkubo, T
    Sugawara, K
    Otani, K
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (7-8): : 1279 - 1283
  • [33] Effects of Glucocorticoids and Oxidative Stress on Monoamine Oxidase A (MAO-A) Activity in the Prefrontal Cortex in Rodents: Implications for Major Depressive Disorder (MDD)
    Raitsin, Sofia
    Tong, Junchao
    Kish, Stephen
    Xu, Xin
    Magomedova, Lilia
    Cummins, Carolyn
    Andreazza, Ana
    Meyer, Jeffrey
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 53S - 54S
  • [34] The Influence of Cigarette Smoking and Major Depressive Disorder on Emotion Processing and Executive Functioning
    Meyers, K. K.
    Crane, N. A.
    O'Day, R.
    Zubieta, J.
    Pomerleau, C. S.
    Horowitz, J. C.
    Langenecker, S. A.
    CLINICAL NEUROPSYCHOLOGIST, 2013, 27 (04) : 580 - 580
  • [35] PET Quantification of Serotonin Transporter Binding in Major Depressive Disorder
    Miller, Jeffrey
    Hurley, Patrick
    Zanderigo, Francesca
    Rubin-Falcone, Harry
    Ogden, R. Todd
    Sublette, M. Elizabeth
    Parsey, Ramin
    Oquendo, Maria
    Mann, J. John
    BIOLOGICAL PSYCHIATRY, 2019, 85 (10) : S329 - S329
  • [36] Reduced Striatal Dopamine Transporter Binding in Major Depressive Disorder
    Wooten, Dustin
    Goer, Franziska
    Beltzer, Miranda
    Vitaliano, Gordana
    Brennan, Brian
    Crowley, David
    Alpert, Nathaniel
    Normandin, Marc
    El Fakhri, Georges
    Pizzagalli, Diego
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [37] Low brain serotonin transporter binding in major depressive disorder
    Newberg, Andrew B.
    Amsterdam, Jay D.
    Wintering, Nancy
    Shults, Justine
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2012, 202 (02) : 161 - 167
  • [38] Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited
    Prins, Jolanda
    Olivier, Berend
    Korte, S. Mechiel
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (08) : 1107 - 1130
  • [39] URINARY MONOAMINE-OXIDASE INHIBITOR AND BENZODIAZEPINE WITHDRAWAL
    PETURSSON, H
    BHATTACHARYA, SK
    GLOVER, V
    SANDLER, M
    LADER, MH
    BRITISH JOURNAL OF PSYCHIATRY, 1982, 140 (JAN) : 7 - 10
  • [40] Monoamine oxidase A gene polymorphism and tryptophan hydroxylase gene polymorphism do not affect the antidepressant response to milnacipran in Japanese patients with major depressive disorder
    Sato, K
    Yoshida, K
    Higuchi, H
    Kamata, M
    Takahashi, H
    Ito, K
    Naito, S
    Narumi, A
    Sugawara, Y
    Shimizu, T
    Itoh, K
    Inoue, K
    Suzuki, T
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (03) : A2 - A2
12345